Table 1.
MOAHLFAP characteristics of the tested population in 2014–2016.
| Characteristics | European baseline series (N 504) | Dental screening and metal series (N 87) | |||
|---|---|---|---|---|---|
| Number of positive reactions n (%) |
Nickel n/N (%) |
Cobalt n/N (%) |
Chromium n/N (%) |
Number of positive reactions n (%) |
|
| Male | 65 (12.9) | 4/65 (6.2) | 4/65 (6.2) | 6/65 (9.2) | 7 (4.0) |
| Occupational | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Atopic dermatitis | 118 (23.4) | 31/118 (26.3) | 12/118 (10.2) | 12/118 (10.2) | 9 (8.0) |
| Hand | 156 (30.7) | 46/156 (29.5) | 19/156 (12.2) | 10/156 (6.4) | 24 (20.0) |
| Leg | 24 (5.4) | 6/24 (25.0) | 2/24 (8.3) | 2/24 (8.3) | 3 (2.0) |
| Face | 232 (47.3)∗ | 65/232 (28.0) | 16/232 (6.9) | 10/232 (4.3) | 65 (78.0)∗ |
| Age > 40 years | 246 (48.8) | 56/246 (22.8) | 14/246 (4.9) | 15/246 (6.1) | 58 (66.0) |
| Positivity rate (≥1 positive reaction) | 288 (57.1) | 149/504 (29.6) | 44/504 (8.7) | 33/504 (6.6) | 61 (66.0) |
N: total number of tested patients.
n: number of positive reactions.
∗ p < 0.0001.